south africa

research consortia phase ii

Mark Hatherill

Mark Hatherill

SATVI-UCT

South African Tuberculosis Vaccine Initiative, University of Cape Town

Gerhard Walzl

Gerhard Walzl

SUN-IRG

Stellenbosch University Immunology Research Group

Timothy Sterling

Timothy Sterling

VUMC

Vanderbilt University Medical Center, USA

Thomas Scriba

Thomas Scriba

SATVI-UCT

South African Tuberculosis Vaccine Initiative, University of Cape Town

Bavesh Davandra Kana

Bavesh Davandra Kana

DST/NRF

DST/NRF Centre of Excellence for Biomedical TB Research

Yuri van der Heijden

Yuri van der Heijden

VUMC

Vanderbilt University Medical Center, USA

Heather Zar

Heather Zar

UCTLI

University of Cape Town Lung Institute, Red Cross Children’s Hospital

Keertan Dheda

Keertan Dheda

UCTLI

University of Cape Town Lung Institute

Rodney Dawson

Rodney Dawson

UCTLI

University of Cape Town Lung Institute

Al Leslie

Al Leslie

AHRI

Africa Health Research Institute

Tumelo Moloantoa

Tumelo Moloantoa

PHRU

University of the Witwatersrand, Perinatal HIV Research Unit

Neil Martinson

Neil Martinson

PHRU

University of the Witwatersrand, Perinatal HIV Research Unit

Bernard Fourie

Bernard Fourie

UP

University of Pretoria

Mark Nicol

Mark Nicol

UWA

University of Western Australia, University of Cape Town

Michele Tameris

Michele Tameris

SATVI-UCT

South African Tuberculosis Vaccine Initiative, University of Cape Town

Stephanus Malherbe

Stephanus Malherbe

SU-IRG

Stellenbosch University Immunology Research Group

Graeme Meintjes

Graeme Meintjes

UCT-CIDRI

University of Cape Town, Centre for Infectious Diseases Research Initiative in Africa

Stephany Norah Duda

Stephany Norah Duda

VUMC

Vanderbilt University Medical Center, USA

John Belisle

John Belisle

CSU

Colorado State University

Karen Dobos

Karen Dobos

CSU

Colorado State University

Sara Suliman

Sara Suliman

BWH

Brigham and Women’s Hospital

Gerard Cangelosi

Gerard Cangelosi

UW

University of Washington